Journal Watch · Frontiers in Immunology · 2026
Integrative genetic and expression profiling prioritizes <i>LIPA</i> in mononuclear phagocytes as a candidate regulator of carotid plaque.
These findings provide preliminary evidence supporting the translational relevance of <i>LIPA</i>-related modulation, pending further validation.
TL;DR
These findings provide preliminary evidence supporting the translational relevance of <i>LIPA</i>-related modulation, pending further validation.
Key findings
- Additionally, dorsomorphin reduced oxLDL-induced <i>LIPA</i> upregulation and lipid accumulation in macrophages.<h4>Conclusion</h4>Our integrative genetic and transcriptomic approach prioritizes <i>LIPA</i> as a mononuclear phagocyte-enriched candidate gene for CP.
- Functional and computational analyses suggest that <i>LIPA</i> may be associated with lipid accumulation, complement-related activation, and SPP1-CD44-associated immune regulation <i>in vitro</i>.
- These findings provide preliminary evidence supporting the translational relevance of <i>LIPA</i>-related modulation, pending further validation.
What they did
Molecular docking and PheWAS were employed to evaluate its translational potential and possible pleiotropic associations.<h4>Results</h4>22 candidate genes for CP were identified. <i>LIPA</i>_Mono_C showed a consistent causal association with increased CP risk in two independent GWAS datasets. Single-cell RNA sequencing confirmed that <i>LIPA</i> was highly expressed in mononuclear phagocytes of CP tissues, and CellChat analysis suggested a potential SPP1-CD44-mediated interaction between <i>LIPA</i>-expressing mononuclear phagocytes and T cells. In silico knockout of <i>LIPA</i> revealed significant enrichment of the complement and coagulation cascades. <i>In vitro</i> experiments verified that oxidized low-density lipoprotein upregulated <i>LIPA</i> in macrophages in a time- and dose-dependent manner. <i>LIPA</i> knockdown alleviated lipid accumulation, suppressed complement activation, attenuated SPP1 expression, and reduced SPP1/CD44-associated T-cell functional readouts <i>in vitro</i>.
Full abstract (original)
Background: <h4>Background</h4>Atherosclerosis shows vascular bed specificity, yet research has focused on coronary arteries, leaving the causal genetics and immune cell-specific mechanisms of carotid plaque (CP) unexplored. This study aims to unbiasedly identify CP candidate genes and evaluate their therapeutic potential.<h4>Methods</h4>Two-sample MR analysis was performed using data from 14 peripheral blood immune cell types and two GWAS datasets for carotid plaque, followed by colocalization analysis to prioritize causal genes. A human carotid plaque single-cell RNA-seq dataset was then integrated to examine cellular expression patterns, cell-cell communication, and functional enrichment. <i>In vitro</i> experiments using THP-1-derived macrophages and Jurkat T cells were conducted to validate the function of the key gene.
What they did: Molecular docking and PheWAS were employed to evaluate its translational potential and possible pleiotropic associations.<h4>Results</h4>22 candidate genes for CP were identified. <i>LIPA</i>_Mono_C showed a consistent causal association with increased CP risk in two independent GWAS datasets. Single-cell RNA sequencing confirmed that <i>LIPA</i> was highly expressed in mononuclear phagocytes of CP tissues, and CellChat analysis suggested a potential SPP1-CD44-mediated interaction between <i>LIPA</i>-expressing mononuclear phagocytes and T cells. In silico knockout of <i>LIPA</i> revealed significant enrichment of the complement and coagulation cascades. <i>In vitro</i> experiments verified that oxidized low-density lipoprotein upregulated <i>LIPA</i> in macrophages in a time- and dose-dependent manner. <i>LIPA</i> knockdown alleviated lipid accumulation, suppressed complement activation, attenuated SPP1 expression, and reduced SPP1/CD44-associated T-cell functional readouts <i>in vitro</i>.
Results & conclusions: Additionally, dorsomorphin reduced oxLDL-induced <i>LIPA</i> upregulation and lipid accumulation in macrophages.<h4>Conclusion</h4>Our integrative genetic and transcriptomic approach prioritizes <i>LIPA</i> as a mononuclear phagocyte-enriched candidate gene for CP. Functional and computational analyses suggest that <i>LIPA</i> may be associated with lipid accumulation, complement-related activation, and SPP1-CD44-associated immune regulation <i>in vitro</i>. These findings provide preliminary evidence supporting the translational relevance of <i>LIPA</i>-related modulation, pending further validation.
Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1861490 · PubMed 42404895.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Frontiers in Immunology study find?
These findings provide preliminary evidence supporting the translational relevance of <i>LIPA</i>-related modulation, pending further validation.
What type of study is this?
It is a in-vitro / cell study, published in Frontiers in Immunology in 2026. Molecular docking and PheWAS were employed to evaluate its translational potential and possible pleiotropic associations.<h4>Results</h4>22 candidate genes for CP were identified.
Where can I read the original paper?
The original is at the publisher via DOI 10.3389/fimmu.2026.1861490. PubMed ID: 42404895. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/integrative-genetic-and-expression-profiling-prioritizes-lt-i-gt-lipa-lt-861490/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides